FDA Warning Letter — Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

Case 725591 — FEI 3004117486

The FDA took a Warning Letter action against Hubei Gedian Humanwell Pharmaceutical Co., Ltd. on June 3, 2026 (Ezhou, China). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.

Action Details

Facility
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
Date
June 3, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Ezhou (China)